GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akari Therapeutics PLC (FRA:CLA) » Definitions » Net Interest Income (for Banks)

Akari Therapeutics (FRA:CLA) Net Interest Income (for Banks)


View and export this data going back to 2017. Start your Free Trial

What is Akari Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Akari Therapeutics (FRA:CLA) Business Description

Industry
Traded in Other Exchanges
Address
75/76 Wimpole Street, London, GBR, W1G 9RT
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system for the treatment of rare and orphan diseases. Its main product candidate includes Coversin, Coversin long acting and Coversin dual action. It operates mainly in United States and United Kingdom.